The largest database of trusted experimental protocols

10 protocols using rabbit igg

1

Constructing EGFP Fusion Vectors of Bovine Immune Regulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to construct EGFP fusion expression vectors of bovine CTLA-4, CD80, CD86, and CD28, we designed the primers to amplify the ORF region that did not have a stop codon. The amplified region fragment of bovine CTLA-4, CD80, CD86, and CD28 was inserted into the cloning site of a pEGFP-N2 vector (Clontech, Palo Alto, CA, USA). The complete vectors, pEGFP-N2-CD80, pEGFP-N2-CD86, and pEGFP-N2-CD28 were transfected into Cos-7 cells by Lipofectamine 2000 reagent (Thermo Fisher Scientific) and cultured for 48 h. The complete vector, pEGFP-N2-CTLA-4 was transfected into CHO-DG44 cells (provided by Dr. Suzuki, Hokkaido University, Japan) with the Lipofectamine LTX reagent (Thermo Fisher Scientific). CTLA-4-EGFP expressing CHO-DG44 cells were cloned and established CTLA-4-EGFP highly expressing CHO-DG44 cells. The binding of CTLA-4-Ig to the CD80 or CD86 expressing cells or the binding of CD80-Ig or CD86-Ig to CTLA-4 expressing cells was confirmed using flow cytometry with FACSVerse (BD Biosciences, San Jose, CA, USA) and FCS Express 4 (De Novo Software, Glendale, CA, USA) as previously described with some modifications [22 (link)]. Rabbit IgG (Southern Biotech, Birmingham, AL, USA) was used as a control Ig.
+ Open protocol
+ Expand
2

Molecular Mechanisms of Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following inhibitors and drugs were used at the indicated concentration unless otherwise specified in the Figure or Figure legends: dinaciclib 50 nM (Selleck-Chemicals, Houston, TX, USA, cat# S2768), NVP-2 50 nM (Selleck-Chemicals Cat# S8981), etoposide (Absource diagnostic, Munich, Germany, cat# S1225-0100), cisplatin (Selleck-Chemicals, cat# S1166), Propidium Iodide (Sigma-Aldrich, Cat# P4864). Recombinant iz-huTRAIL was provided by H. Walczak. Antibodies against the following antigens were used: RNA pol II RBP1 pSer2 (Biolegend, San Diego, CA, USA, cat# 920204), RNA pol II (Biolegend, cat# 904001), MCL-1 (Cell Signalling, Danvers, MA, USA, cat# 5453), cFLIP (Cell Signalling, cat# 56343), C-Myc (Cell Signalling, cat# 5605), PARP (BD, Franklin Lakes, NJ, USA, cat# 556362), caspase 9 (Abcam, Cambridge, UK, cat# 202068), caspase 8 (Cell Signalling, cat# 9746), cleaved caspase 3 (Cell Signalling, cat# 9664), β-Actin (Sigma-Aldrich, cat# A1978), Tubulin (Sigma-Aldrich, cat# T9026), Rabbit IgG (SouthernBiotech, Birmingham, AL, USA, cat# 4050-05), Mouse IgG (SouthernBiotech, cat# 1031-05). VC-1 was produced and provided by Vichem Chemie Research Ltd.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of B4GALNT3 in Colorectal Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human colorectal cancer tissue sections were de-paraffinized in xylene and re-hydrated in a series of graded alcohols. After rinsing twice with PBS, the sections were then quenched the activity of endogenous peroxidase with Ultravision Hydrogen Peroxide Block (Thermo scientific, Barrington, IL) for 10 min and incubated with Ultravision Protein Block (Thermo scientific, Barrington, IL) for 10 min to reduce non-specific binding. Sections were incubated with an rabbit anti-B4GALNT3 polyclonal antibody (Sigma, St. Louis, MO, 1:100) diluted with 1% bovine serum albumin (MDBio, Inc., Taipei, Taiwan)/PBS for 16 h at 4 °C. After rinsing twice with PBS, the sections were processed using the Ultravision Quanta Detection System (Thermo scientific, Barrington, IL). Specific immuno-staining was visualized with DAB Quanto (Thermo scientific, Barrington, IL). All sections were counterstained with hematoxylin for 1 min and mounted with UltraKitt (J.T. Baker, Deventer, Holland). Negative controls were performed by replacing primary antibodies with rabbit IgG (SouthernBiotech, Birmingham, AL) at the same concentration.
+ Open protocol
+ Expand
4

NK Cell Depletion in Ischemia-Reperfusion Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
For NK1.1 depleting experiments, B6 and CD1d knock out mice were treated with either 200μg control α-mouse IgG2a (BioXCell C1.18.4, mouse IgG2a Isotype control) or α-NK1.1 (BioXCell PK136) on day −3 and −1. For Asialo-GM1 depleting experiments, B6 mice were treated with 800μg of either rabbit IgG (Southern Biotech) or AsGM1 (WAKO) on day −1. On day 0, mice were then subjected to hanging weight system for 30 minutes to induce IRI. After 1 day of reperfusion, kidney function was measured by GFR. NK cell depletion was verified by measuring NK cell percentages (CD45+CD3−NKp46+).
+ Open protocol
+ Expand
5

Comprehensive Antibody Characterization Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following commercially available antibodies used were: anti-PAI-1 (clone 41/PAI-1; BD Biosciences), anti-p53 (DO-1; Calbiochem), anti-β-actin (AC-15; Sigma), anti-phospho-Smad2 (Ser465/467) (138D4; Cell Signaling Technology), anti-Smad2/3 (clone 18/Smad2/3; BD Bioscience), anti-CBP (A-22; Santa Cruz Biotechnology), anti-acetyl-Histone H3 (catalog no. 06–599; EMD Millipore), anti-Myc (4A6; EMD Millipore), anti-FLAG (M2; Sigma), anti-HA (Y-11; Santa Cruz Biotechnology), and anti-GFP (B-2; Santa Cruz Biotechnology). Mouse immunoglobulin G1 (IgG1) (MB002; R & D Systems) and rabbit IgG (Southern Biotech) were used as controls.
+ Open protocol
+ Expand
6

Feline PD-1 and PD-L1/PD-L2 Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To examine whether feline PD-1 binds to PD-L1/PD-L2, 2 × 105 fePD-1–EGFP- and fePD-L1–EGFP-expressing cells were incubated for 30 min with 10 μg/mL of either fePD-1–Ig, fePD-L1–Ig, or fePD-L2–Ig at room temperature (RT), followed by another 30 min incubation with Alexa Fluor 647-conjugated F(ab′)2-goat anti-Rabbit IgG (H+L) secondary antibody (Thermo Fisher Scientific). Rabbit IgG (Southern Biotech) was used as a control protein. Cell fluorescence was analyzed using BD FACSLyric system (BD Biosciences, Franklin Lakes, NJ, USA).
To examine PD-L1 expression on cell lines, 2 × 105 cells were incubated for 30 min with 10 μg/mL CL1Mab-7 or mouse IgG1κ isotype-matched control antibody (15H6; Southern Biotech) at RT, followed by another 30 min incubation with Alexa Fluor 647-conjugated F(ab′)2-goat anti-mouse IgG (H+L) secondary antibody (Thermo Fisher Scientific). Cell fluorescence was analyzed using BD FACSLyric system (BD Biosciences). For fePD-1–EGFP- and fePD-L1–EGFP-expressing cells, only EGFP-positive cells were gated and subjected to further analysis.
+ Open protocol
+ Expand
7

Depletion of NK Cells in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
For systemic depletion of NK cells, we chose treatment with anti-asialo GM1 antibody, which has been used as a precise tool for the specific elimination of NK cells.59 (link) C57 BL/6 mice were given intraperitoneal injections of anti-asialo GM1 antibody (10 µL diluted in 100 µL PBS/mouse, Wako Pure Chemicals, Osaka, Japan) or control (rabbit IgG, Southern Biotech, Birmingham, AL, USA) on days -3, 0, 3, 6, 9 and 12 relative to the injection of B16F0 cells.
+ Open protocol
+ Expand
8

TGF-α Neutralization in Organoid Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tspan6 wild-type and Tspan6−/− organoids were cultured in mouse intestinal organoid media without EGF in the presence of TGF-α neutralizing antibody (SI Appendix, Table S1) in serial dilutions (2.5, 5, 10, and 20 µg/mL) or control antibody (Rabbit IgG, Southern Biotech). Organoids were cultured for 7 d, and images were acquired using the Zeiss Axiovert 25 microscope equipped with Scion Corporation Greyscale camera, and images were analyzed using ImageJ.
+ Open protocol
+ Expand
9

Nephrotoxic Serum-Induced Glomerulonephritis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Nephrotoxic serum nephritis was induced as described previously 21,22. Briefly, mouse glomeruli were isolated from female BALB/c mice and sonicated, and this antigenic preparation was used for immunization of rabbits 27. Rabbit serum collected after sufficient antibody titres were achieved was used as nephrotoxic serum (NTS). Wild-type B6 and B7x -/-mice were primed intraperitoneally (i.p.) with 250 μg of rabbit IgG (Southern Biotech, Birmingham, AL, USA) emulsified with complete Freund's adjuvant (CFA) (Sigma-Aldrich, St Louis, MO, USA) on day 0. On day 5, mice received an intravenous injection of either nephrotoxic serum or phosphatebuffered saline (PBS). Blood and urine were collected at baseline (day 0) and at day 12. Mice were killed on day 12, and kidney tissues were harvested for analysis by histopathology, immunohistochemistry, immunofluorescence and mRNA expression levels. The spleens were obtained for analysis of macrophages, T cells and B cells by flow cytometry.
+ Open protocol
+ Expand
10

Modulating Immune Responses in Melanoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
To deplete NK cells, mice received anti-Asialo GM 1 antibodies (1 mg/ml, EBio-Science) or isotype antibodies as control (Rabbit IgG, 0.5 mg/ml, Southern Biotech) every second day from 1 week before B16 inoculation. Five days after tumor cell inoculation, NK cells content was evaluated. Propranolol/Epinephrine Study Eight-week-old C57BL/6 mice were randomized to drinking water containing 0.5 g/l propranolol or nothing. Propranolol administration started 1 week before B16 inoculation. An additional group received daily (Monday to Friday) injections of epinephrine (0.5 mg/kg, 200 ml i.p.) from 1 week before B16 inoculation. For the acute effect of epinephrine, mice were injected with 0.5 mg/kg or 2 mg/kg epinephrine, and sacrified after 30 min, where blood, spleen, and muscle tissue were collected. Anti-IL-6/IL-6 Study Eight-week-old C57BL/6 mice were randomized to groups, receiving i.p. injections of anti-IL-6 antibodies (100 mg/mouse, R&D systems, #AB-406-NA) or vehicle injections twice a week from 1 week before B16 inoculation. An additional group received daily (Monday to Friday) injections of IL-6 (100 ng/mouse, R&D systems, #406-ML-025/CF) from 1 week before B16 inoculation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!